HS
Hetal Sanjay Patolia
About Hetal Sanjay Patolia
Hetal Sanjay Patolia has 15 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including New Life Obesity Care Private Limited and Enloc Energy Transition Private Limited. Formerly with 1 company, such as Asian Med Horizon Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
New Life Obesity Care Private Limited
U35105GJ2008PTC054260
|
Director | 23 Mar 2011 | 2008 | Active |
Enloc Energy Transition Private Limited
U35105GJ2025PTC167487
|
Director | 09 Sep 2025 | 2025 | Active |
Nutraease Llp
ACI-8736
|
Designated Partner | 09 Aug 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Asian Med Horizon Private Limited
U85110GJ2011PTC066728
|
Additional Director | 28 Oct 2013 | 2011 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hetal Sanjay Patolia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hetal Sanjay Patolia
Hetal Sanjay Patolia has 15 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including New Life Obesity Care Private Limited and Enloc Energy Transition Private Limited. Formerly with 1 company, such as Asian Med Horizon Private Limited. Engaged in General Business. Contributes to corporate operations.
Hetal Sanjay Patolia is associated with 3 companies as Director and Designated Partner.
Hetal Sanjay Patolia has expertise in General Business.
Hetal Sanjay Patolia has 15 years in corporate governance.